You have 9 free searches left this month | for more free features.

crizanlizumab

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sickle Cell Disease Trial (Crizanlizumab, control)

Not yet recruiting
  • Sickle Cell Disease
  • Crizanlizumab
  • control
  • (no location specified)
Jul 19, 2022

RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy Trial in Saint Louis, Philadelphia (Crizanlizumab)

Active, not recruiting
  • RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
  • Crizanlizumab
  • Saint Louis, Missouri
  • +1 more
Jan 27, 2022

COVID-19 Trial in Baltimore (Crizanlizumab, 0.9% saline)

Completed
  • COVID-19
  • Crizanlizumab
  • 0.9% saline
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 3, 2021

Sickle Cell Disease (SCD) Trial in India (crizanlizumab)

Recruiting
  • Sickle Cell Disease (SCD)
  • crizanlizumab
  • Hyderabad, Andhra Pradesh, India
  • +7 more
Mar 31, 2022

Priapism Trial in United States (crizanlizumab)

Recruiting
  • Priapism
  • crizanlizumab
  • Birmingham, Alabama
  • +18 more
Jan 17, 2023

Sickle Cell Disease Trial in Worldwide (Crizanlizumab)

Recruiting
  • Sickle Cell Disease
  • Crizanlizumab
  • Birmingham, Alabama
  • +19 more
Jun 20, 2022

Sickle Cell Disease (SCD) Trial in United States (crizanlizumab)

Active, not recruiting
  • Sickle Cell Disease (SCD)
  • crizanlizumab
  • Orange City, Florida
  • +11 more
Apr 25, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +37 more
Aug 18, 2022